1. Home
  2. MBX vs CWCO Comparison

MBX vs CWCO Comparison

Compare MBX & CWCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBX
  • CWCO
  • Stock Information
  • Founded
  • MBX 2018
  • CWCO 1973
  • Country
  • MBX United States
  • CWCO Cayman Islands
  • Employees
  • MBX N/A
  • CWCO N/A
  • Industry
  • MBX
  • CWCO Water Supply
  • Sector
  • MBX
  • CWCO Utilities
  • Exchange
  • MBX NYSE
  • CWCO Nasdaq
  • Market Cap
  • MBX 347.9M
  • CWCO 402.4M
  • IPO Year
  • MBX 2024
  • CWCO N/A
  • Fundamental
  • Price
  • MBX $6.97
  • CWCO $24.38
  • Analyst Decision
  • MBX Strong Buy
  • CWCO
  • Analyst Count
  • MBX 4
  • CWCO 0
  • Target Price
  • MBX $37.25
  • CWCO N/A
  • AVG Volume (30 Days)
  • MBX 223.9K
  • CWCO 195.4K
  • Earning Date
  • MBX 03-17-2025
  • CWCO 03-17-2025
  • Dividend Yield
  • MBX N/A
  • CWCO 1.80%
  • EPS Growth
  • MBX N/A
  • CWCO N/A
  • EPS
  • MBX N/A
  • CWCO 1.77
  • Revenue
  • MBX N/A
  • CWCO $133,966,633.00
  • Revenue This Year
  • MBX N/A
  • CWCO N/A
  • Revenue Next Year
  • MBX N/A
  • CWCO $62.30
  • P/E Ratio
  • MBX N/A
  • CWCO $13.79
  • Revenue Growth
  • MBX N/A
  • CWCO N/A
  • 52 Week Low
  • MBX $6.67
  • CWCO $23.55
  • 52 Week High
  • MBX $27.50
  • CWCO $30.32
  • Technical
  • Relative Strength Index (RSI)
  • MBX N/A
  • CWCO 35.22
  • Support Level
  • MBX N/A
  • CWCO $24.05
  • Resistance Level
  • MBX N/A
  • CWCO $24.92
  • Average True Range (ATR)
  • MBX 0.00
  • CWCO 0.91
  • MACD
  • MBX 0.00
  • CWCO -0.30
  • Stochastic Oscillator
  • MBX 0.00
  • CWCO 14.41

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

About CWCO Consolidated Water Co. Ltd.

Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties, and The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal and industrial water production, supply and treatment.

Share on Social Networks: